| FDA Clears Glaxo Vaccine The FDA said vaccines to protect infants against rotavirus are safe, removing its recommendation that doctors suspend use of GlaxoSmithKline's Rotarix. online.wsj.com |
Early Alzheimer's Diagnosis Yields Savings Early diagnosis of cognitive impairment can yield substantial savings in medical costs for Alzheimer's patients, according to a new study. online.wsj.com |
Genzyme in Talks With Sanofi French drug maker Sanofi-Aventis entered into friendly takeover talks with U.S. biotech firm Genzyme, sending a letter detailing its takeover offer of $69 a share. online.wsj.com |
Biosciences and Growth Michael Mandel submits:Over the medium-term, I regard biosciences–pharma, medical devices, broader applications of biotech–as one of the key 2 or 3 drivers of U.S. economic growth. The elements are all lined up: Great science, skilled workers, enormous potential demand. So 5-10 years from now, we’re likely to be reading about the founder of some hot biosciences firm joining Mark Zuckerberg as the latest multizillionaire. But in the short-term: Oh, lordy. The latest blow comes from the recent decisions to ban the diabetes drug Avandia in Europe and greatly restrict its use in the U.S. Let me quote from Derek Lowe, a pharma researcher:Complete Story » seekingalpha.com |
UnitedHealth Net Rises 23% UnitedHealth's profit jumped 23% as claim costs fell and the company reported commercial-membership gains. online.wsj.com |